BioWorld

April 10, 2006

View Archived Issues

'Extensive' Bidding War Ends With Pfizer Taking Over Rinat

After an almost year-long respite, Pfizer Inc. is throwing money on the biotech table again, this time entering an agreement to buy privately held Rinat Neuroscience Corp. for an undisclosed sum. (BioWorld Today) Read More

Midwest's Chance To Shine: BIO 2006 Arrives In Chicago

Read More

Four Points Of Concern As Biotechnology Grows

Read More

Cougar Goes Public Through Reverse Merger, Raises $47M

Read More

Biotech Execs Ask For BioShield Reform; Security, Money At Issue

Read More

Medarex's Public Offering Gets $112M For R&D, Clinical Work

Read More

Other News To Note

Read More